Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Injectable once weekly
This outcome does not reflect personal failure but rather the biological reality that obesity involves persistent dysregulation of appetite and metabolism that requires ongoing management
It is not among the most frequent adverse effects gastrointestinal reactions such as nausea, vomiting, and reduced appetite are reported far more often
[1] The pivotal SURMOUNT clinical trial program, which evaluated tirzepatide for weight management in over 5,000 participants, did not identify leg pain as a statistically significant adverse event occurring at notably higher rates than placebo
Different people respond differently to certain medications, so changing might be more helpful for you in achieving your goals
Personal Protective Equipment (PPE) Sterile gloves are highly recommended
